Protagonist Therapeutics PTGX Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Protagonist Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The official record: Protagonist Therapeutics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Protagonist Therapeutics's total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Protagonist Therapeutics's total current liabilities?
- Protagonist Therapeutics (PTGX) reported total current liabilities of $34.55M in Q1 2026.
- How has Protagonist Therapeutics's total current liabilities changed year-over-year?
- Protagonist Therapeutics's total current liabilities decreased by 1.6% year-over-year, from $35.11M to $34.55M.
- What is the long-term trend for Protagonist Therapeutics's total current liabilities?
- Over 5 years (2020 to 2025), Protagonist Therapeutics's total current liabilities has grown at a 2.5% compound annual growth rate (CAGR), from $40.24M to $45.44M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.